Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000148

EVP & Chief Financial Officer sold 3,298 shares at $500.00 ($1,649,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WAGNER CHARLES F JR · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Sale : show line 1 in the form 10b5-1 −3,298 $500.00 $1,649,000 51,671 D
Open-market sales · 3,298 sh · avg $500.00 · $1,649,000
Loading xslF345X05/wk-form4_1741810299.xml…